Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|7|537-564

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.7, 2003-01, pp. : 537-564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives

By  

Current Drug Targets, Vol. 4, Iss. 7, 2003-10 ,pp. : 565-585

Bentham Science Publishers

Access to resources Recommend Favorite

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 9, Iss. 26, 2003-10 ,pp. : 2155-2175

Bentham Science Publishers

Access to resources Recommend Favorite

Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Approaches for the Selective Killing of Cancer Cells

By  

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1683-1694

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody Directed Enzyme Prodrug Therapy (ADEPT) and Related Approaches for Anticancer Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 4, 2001-11 ,pp. : 399-407

Bentham Science Publishers

Access to resources Recommend Favorite